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ABSTRACT
Objective To estimate the incidence of avoidable 
significant harm in primary care in England; describe 
and classify the associated patient safety incidents and 
generate suggestions to mitigate risks of ameliorable 
factors contributing to the incidents.
Design Retrospective case note review. Patients with 
significant health problems were identified and clinical 
judgements were made on avoidability and severity 
of harm. Factors contributing to avoidable harm were 
identified and recorded.
Setting Primary care.
Participants Thirteen general practitioners (GPs) 
undertook a retrospective case note review of a sample 
of 14 407 primary care patients registered with 12 
randomly selected general practices from three regions in 
England (total list size: 92 255 patients).
Main outcome measures The incidence of significant 
harm considered at least ’probably avoidable’ and the 
nature of the safety incidents.
Results The rate of significant harm considered at least 
probably avoidable was 35.6 (95% CI 23.3 to 48.0) 
per 100 000 patient- years (57.9, 95% CI 42.2 to 73.7, 
per 100 000 based on a sensitivity analysis). Overall, 
74 cases of avoidable harm were detected, involving 
72 patients. Three types of incident accounted for more 
than 90% of the problems: problems with diagnosis 
accounted for 45/74 (60.8%) primary incidents, followed 
by medication- related problems (n=19, 25.7%) and 
delayed referrals (n=8, 10.8%). In 59 (79.7%) cases, 
the significant harm could have been identified sooner 
(n=48) or prevented (n=11) if the GP had taken actions 
aligned with evidence- based guidelines.
Conclusion There is likely to be a substantial burden 
of avoidable significant harm attributable to primary 
care in England with diagnostic error accounting for 
most harms. Based on the contributory factors we 
found, improvements could be made through more 
effective implementation of existing information 
technology, enhanced team coordination and 
communication, and greater personal and informational 
continuity of care.
INTRODUCTION
Healthcare- associated harm is an inter-
nationally recognised threat to public 
health and well- being. Across all income 
settings, as many countries aspire towards 
universal health coverage, attention has 
focused on the critical role of primary 
care- led healthcare systems to help 
achieve this goal.1 2 In countries like the 
UK, over 90% of clinical encounters are 
delivered in community settings,3 but a 
clear understanding of avoidable harm is 
needed to enable healthcare systems to 
identify and learn from the most serious 
incidents and the factors amenable to 
intervention.
Most patient safety research has focused 
on hospital- based care settings resulting in 
a greater awareness of the frequency and 
causes of health care- associated errors, and 
the resulting burden to patients.4 Patient 
safety research in primary care has been 
slower,2 5 although the profile of patient 
safety in primary care was provided a 
platform by the WHO’s Safer Primary 
Care Expert Group (2012) and catalysed 
more recently by the US National Patient 
Safety Foundation’s call to look ‘beyond 
hospitals to the full care continuum’ and 
the Organisation for Economic Co- opera-
tion and Development’s assessment of the 
economic burden of unsafe primary and 
ambulatory care.6–8 The WHO’s Tech-
nical Series for Safer Primary Care, where 
world experts have explored the existing 
evidence base for primary care safety, 
highlighted that major evidence gaps exist 
and robust high- quality epidemiological 
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studies are needed to definitively establish the burden 
of unsafe primary care.9 While harm from hospital- 
based care may be more visible, given the volume of 
patient consultations that occur in primary care, the 
aggregate burden of harm cannot be ignored.7
Our WHO- commissioned systematic review inves-
tigating the frequency and burden of harm in general 
practice concluded 2%–3% of primary care encoun-
ters involved a patient safety incident, and around 1 
in 25 of those resulted in a significant harm outcome 
that has a substantial impact on a patient’s well- being.8 
Included studies were notably heterogeneous in study 
design and definitions of outcome measures. None 
of the primary care studies in this, or our subsequent 
systematic review,10 reported the incidence of avoid-
able harm11 12 based on independent review of medical 
records, and few distinguished between minor and 
more significant harms.13 Also, we are aware of only 
one previous study that was large enough to identify 
substantial numbers of significant harms but did not 
report on these in detail.13 This means that based on 
the literature, it has not been possible to reliably quan-
tify the overall burden of avoidable significant patient 
harm in primary care.
We have addressed this issue in the current study 
by undertaking a large retrospective case note review 
study using independent clinical reviewers to (1) esti-
mate the incidence of avoidable significant harm in 
primary care in England; (2) quantify, describe and 
classify the patient safety incidents that result in avoid-
able significant harm (thus showing the top categories 
of avoidable harm) and (3) generate suggestions to miti-
gate risks of ameliorable factors that contributed to the 
incidents. Our study is different from other primary 
care studies because of its specific focus on identifying 
and understanding significant harm, and because it has 
estimated the incidence (rather than prevalence) of 
harm on the basis that this provides policy makers with 
a better idea of the potential burden of the problem. 
We have used a definition of avoidable harm based 
on a consensus study panel with general practitioners 
(GPs)14 using real cases of unsafe general practice from 
our earlier national- level analysis of patient safety inci-
dent reports.15
METHODS
Our study protocol describes the methods we employed 
in detail,16 and an expanded version of our methods is 
in the online supplemental materials. Box 1 provides 
the definitions used in the study.
Participants
We used a stratified random sampling approach to 
invite general practices to participate from three 
different areas of England. We undertook a retrospec-
tive case note review of an open cohort of all primary 
care patients registered with participating general 
practices (between 1 April 2015 and 31 March 2016) 
to identify cases of avoidable significant harm.
Recruitment and training of data collectors
GPs with at least 5 years’ experience in general practice 
were recruited to collect data from the participating 
practices and were provided with training.16
Sampling of patient records
We sampled patient records in three stages. In stage 1, 
we identified the total patient population of the prac-
tices at the start of the retrospective cohort (1 April 
2015). In stage 2, we used electronic registry queries 
to identify patients at increased risk of significant 
health problems and/or avoidable significant harm (the 
‘enhanced sample’). Drawing on suggestions made by 
the research commissioners, the literature on avoid-
able harm in primary care8 and our own experience 
of analysing reports of harm associated with primary 
care,15 we included patients who had died17 been 
admitted to secondary care,18 were resident in a care 
home,19 had multimorbidity15 or polypharmacy,20 21 
had undergone an invasive procedure in general prac-
tice22 or had been certified unfit for work long term. 
In stage 3, one of the GP data collectors screened 
the electronic health record of each patient in the 
enhanced sample to identify any new significant health 
Box 1 Definitions used in our study
Significant harm
Our definition of significant harm was informed by the 
international classification of patient safety definitions of 
moderate harm, severe harm and death outcomes.44 The 
definition used was as follows:
‘A patient outcome is symptomatic, which required 
more intensive intervention than might otherwise have 
been required (eg, additional operative procedure) and 
resulted in an escalation of care (eg, hospital admission) 
or death. This caused a loss of function of at least one 
bodily organ, which may have been a temporary or 
permanent loss of its function’.
Avoidability
Our definition of avoidability was informed by 
our RAND/University of California Los Angeles 
appropriateness methods study14 to contextualise our 
definition of significant harm. The definition used was as 
follows:
‘A patient safety incident could have probably, or 
totally been avoided by the timely intervention of a health 
care professional in family practice (eg, investigations, 
treatment, safety netting) and / or an administrative 
process (eg, referrals, alerts in electronic health records, 
procedures for following up results) in accordance with 
accepted standards of evidence- based practice and / or 
clinical governance and / or the Bolam test’.45
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problems experienced by patients over the 12 months 
of the study (1 April 2015–31 March 2016). The GPs 
then undertook detailed retrospective reviews of the 
records of this final sample of patients to identify the 
extent to which errors in primary healthcare provision 
contributed to these problems.
For the purposes of sensitivity analysis (recognising 
that cases might have been missed by our sampling 
approach), the GP data collectors also undertook a 
detailed records review for the following:
 ► 2.5% random sample of the stage 1 population, not 
including patients identified for the stage 2 enhanced 
sample; each record was examined by a single GP 
reviewer.
 ► 10% random sample of the stage 2 enhanced sample; 
each record was examined by a second GP reviewer.
Identification of avoidable significant harm and factors 
associated with this
For those patients with significant health prob-
lems, the GP data collectors recorded whether they 
found any evidence of avoidable harm. If so, the GPs 
provided a detailed written account of the principal 
problem in the patient’s primary care that led to the 
significant health problem, a narrative describing the 
manner in which the significant health problem could 
have potentially been prevented within primary care, 
and a judgement on the avoidability of the significant 
health problem using a validated 6- point scale (see 
table 1).17 23 All cases were considered in detail by the 
study team, and the GP data collectors were asked 
to provide additional information if any clarification 
were needed. To ensure consistency, the study team 
made the final judgement, through consensus, in terms 
of the classification of avoidable significant harm.
Data collection and coding
Each of the participating general practices was 
visited by an informatician from the study team who 
collected baseline data on the practice population 
and ran a computer search to identify patients for 
the enhanced sample and for the sensitivity analyses. 
Using encrypted tablet computers and a virtual private 
network connection, the GP data collectors entered 
anonymised data directly into a database on a secure 
server at Cardiff University. The nature of the avoid-
able harm was recorded by the GP data collectors 
using the comprehensive patient safety classification 
system developed in the Primary Care Patient Safety 
Classification study.24
Analysis
We estimated the incidence of significant harm that 
was considered at least probably avoidable (our 
primary outcome—avoidability score of 4 or more) 
and at least possibly avoidable (avoidability score 3 or 
more) accompanied by 95% CIs.16 We assessed inter- 
rater reliability of judgements made using the Cohen’s 
kappa statistic (with 95% CI).
Members of the study team then undertook a 
detailed analysis of the information provided on each 
case of potentially avoidable significant harm and 
included cases with at least ‘slight to modest’ (score 
or more) evidence of avoidability, as we judged that 
even in these cases there were important insights. We 
analysed the data recorded on the cases and examined 
the relationships between different types of incident 
and the factors that contributed to these incidents. 
As a result, we identified the most important factors 
contributing to avoidable significant harm.
RESULTS
Twelve practices were recruited (as shown in figure 1) 
and table 2 shows their characteristics compared with 
national averages for England. The practices were 
similar to the English average in terms of list size, 
Index of Multiple Deprivation, and age and gender 
of patients, but had a higher percentage of non- white 
patients. Also, all the participating practices were rated 
overall as ‘good’ or ‘outstanding’ by the Care Quality 
Commission (CQC), whereas almost 12% of the prac-
tices in England received ‘inadequate’ or ‘requires 
improvement’ scores.
The total list size for the 12 general practices at the 
start date of the study cohort (1 April 2015) was 92 
255 (Stage 1). The total number of patient- years of 
clinical data available for the 92 255 patients over the 
year of the cohort (1 April 2015–31 March 2016) was 
89 779.
The flow of patient records through the study is 
shown in figure 2. The computer searches identified 12 
080 patients (13.1%) for the enhanced sample (stage 
2). Their records were all examined by at least one 
GP data collector (first GP data collector in figure 2), 
and 1271 (10.5% random sample) were examined 
independently by a second GP data collector. From 
the stage 1 population of 92 255, a random sample 
of 2327 (2.5%) patients (but not included in the 
enhanced sample) was examined by one of the GP data 
collectors.
Based on the assessment of the GP data collector 
doing the first assessment on the enhanced sample, 
Table 1 Six- Point Avoidability Scale17 23
Rating Category Description
1 Totally unavoidable Virtually no evidence of avoidability
2 Unavoidable Slight to modest evidence of 
avoidability
3 Possibly avoidable Possibly avoidable, less than 50–50, 
but close call
4 Probably avoidable Probably avoidable, more than 
50–50, but close call
5 Probably avoidable Strong evidence of avoidability
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there were 2131 new significant health problems for 
2116 patients between 1 April 2015 and 31 March 
2016 (stage 3; see figure 2). For 2054 (96.4%) of the 
significant health problems, the GP data collector 
judged that the patient had received an adequate stan-
dard of care and therefore classified these cases as 
having ‘virtually no evidence of avoidability’.
For the remaining 77 (3.6%) cases, the first GP 
reviewer formally assessed avoidability and the distri-
bution of avoidability scores, following moderation by 
the study team, is shown in table 3. A further 10 cases 
had ‘virtually no evidence of avoidability’, meaning 
that in total, 2064 (96.9%) of the 2131 significant 
health problems were considered unavoidable in 
primary care.
There were 32 cases (1.5%) of significant harm 
considered to be at least probably avoidable and 51 
(2.4%) considered at least possibly avoidable. This 
translates into a rate of 35.6 per 100 000 patient- years 
(95% CI 23.3 to 48.0) for significant harm consid-
ered at least probably avoidable and 56.8 per 100 000 
patient- years (95% CI 41.2 to 72.4) at least possibly 
avoidable.
Sensitivity analysis
The examination of the 2.5% sample of the patient 
population did not identify any additional cases of 
significant harm considered at least possibly avoidable. 
The examination of the 10% sample of the enhanced 
sample by a second GP reviewer identified two further 
cases of significant harm considered to be at least 
probably avoidable and four cases considered at least 
possibly avoidable, based on the final judgement of the 
study team. This means that had all the patient records 
in the enhanced sample been assessed independently 
by two GPs, there could have been an additional 20 
cases considered at least probably avoidable, and 40 
cases of significant harm considered at least possibly 
avoidable. In the sensitivity analysis, this translated 
into rates of 57.9 (95% CI 42.2 to 73.7) per 100 000 
patient- years for significant harm considered at least 
probably avoidable, and 101.4 (95% CI 80.5 to 122.2) 
per 100 000 patient- years for significant harm consid-
ered at least possibly avoidable.
Inter-rater reliability
Where an assessment of avoidability was done, there 
was 77.0% agreement between GP data collectors and 
the study team about whether the case was considered 
at least possibly avoidable (Cohen’s kappa: 0.49, 95% 
CI 0.29 to 0.69). For the 10% sample of the enhanced 
sample, there was 71.5% agreement between the first 
and second GP reviewers that a patient had at least one 
significant health problem (kappa: 0.33, 95% CI 0.27 
to 0.38), and where an avoidability assessment was 
done independently by two GP data collectors, there 
was a 67.6% agreement about whether the signifi-
cant harm was considered at least possibly avoidable 
(kappa: 0.34, 95% CI: 0.02 to 0.66).
Analysis of the nature and causes of avoidable 
significant harm
For the detailed analysis of the nature and causes of 
avoidable significant harm, we included 74 cases 
involving 72 patients. The distribution of avoidability 
scores for these cases is shown in table 4.
The distribution of different types of primary inci-
dents for the 74 cases is shown in table 5, with problems 
with diagnosis accounting for 60.8%; medication- 
related problems for 25.7% and delayed referrals for 
10.8% (the latter relating to situations where a clini-
cian had decided that a referral was needed, but there 
was such a delay in the referral being made that the 
patient may have been harmed as a result). Exam-
ples of these incidents are shown in boxes 2 and 3. In 
relation to the 74 primary incidents, 114 underlying 
‘contributory factors’ were identified, and these are 
shown in table 6. Patient factors accounted for 71.9%, 
with comorbidities or multimorbidities being the 
most important categories (24.6% of all contributory 
factors), while 17.5% of factors included issues such as 
not taking medicines as prescribed, problems with elic-
iting relevant information from patients or caregivers, 
not following medical advice and presenting with 
multiple issues in a single consultation. Factors such as 
multimorbidity and frailty contributed either through 
offering alternative explanations for symptoms or 
Figure 1 Flowchart showing how practices were recruited.
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by presenting clinicians with multiple competing 
demands. Organisational factors accounted for 21.1% 
of contributory factors, while staff factors such as 
inadequate knowledge, skills or mistakes by health-
care professionals accounted for 7.0%. In 59 (79.7%) 
of the 74 cases, the significant harm could have been 
identified sooner (48 cases) or prevented (11 cases) if 
the GP had taken actions aligned with evidence- based 
guidelines (see examples in box 2).
These 74 cases involved 115 healthcare professionals 
(81 (70.4%) GPs and 10 (8.7%) practice nurses), and 
only 4 of these (3.5%) were clearly identifiable as 
being from outside the participating general practices 
(community nurse, community optometrist, commu-
nity physiotherapist and community psychiatric nurse).
DISCUSSION
Principal findings
The estimated incidence of significant harm in English 
primary care considered at least ‘probably’ avoidable 
is between 35.6 and 57.9 per 100 000 patient- years 
(the latter figure being based on sensitivity analysis). 
Extrapolating our findings to the English population 
of 55.6 million (mid- year 2017), we found that there 
are likely to be between 19 800 and 32 200 cases of 
‘probably avoidable’ significant harm to patients each 
year.
The three major sources of significant avoidable harm 
in general practice were diagnostic error (60.8% of 
the avoidable incidents), medication incidents (25.7%) 
and delayed referrals (10.8%). In 79.7% of cases, the 
Figure 2 Stages of the study and flow of patient records through the study. GP, general practitioner.
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significant harm could have been identified sooner or 
prevented if the GP had taken actions aligned with 
evidence- based guidelines. The study identified a mix 
of organisational, clinician and patient contributory 
factors associated with the avoidable incidents. The 
majority of these were patient factors (71.9% of the 
total contributory factors identified), including multi-
morbidity, old age and complexity arising from patho-
physiological factors such as frailty. Most of these 
factors are not ameliorable but highlight the challenges 
that healthcare professionals face when trying to avoid 
patients coming to harm. Of the organisational factors, 
problems relating to continuity and coordination of 
care (between providers and within primary care) were 
most important (14.1% of the total). For example, 
the patient did not experience a ‘seamless service’ 
due to failures in coordination and sharing of infor-
mation between different providers across the health 
and social care system, disconnect between multiple 
members of the primary care in the same practice and 
lack of care coordination as a patient transitions from 
secondary back to primary care. Mitigating risk for 
future patients could be achieved through targeting 
the organisational structures and processes underpin-
ning the most frequent contributing factors.
Strengths and limitations of the study
This is one of the most comprehensive studies of avoid-
able harm in primary care,8 10 and one of only two 
records review studies we are aware of that is large 
enough to report on substantial numbers of significant 
harms.13 It is the only study of which we are aware 
that has reported the incidence of avoidable harm 
based on independent review of primary care clinical 
records. In terms of other potential methods of investi-
gation, independent retrospective case note review has 
significant advantages over incident reports, which are 
more at risk of selection bias and are not well suited to 
accurately estimating the incidence of avoidable harm. 
It also has advantages over database studies because 
detailed examination is required of the healthcare 
records (including hospital correspondence), which 
is not possible through clinical databases. One major 
limitation of case note review is the onerous task of 
searching for and identifying important information to 
build a narrative, based on what is explicitly stated or 
from what is absent based on the clinician’s knowledge 
of the relevant evidence- based guidelines.
We used a stratified random sampling approach to 
recruit 12 general practices from three geographi-
cally different regions of England, and the indepen-
dent GPs involved in data collection were experienced 
and were given thorough training. We used a vali-
dated method for judging the avoidability of harm14 
and a comprehensive validated system for classi-
fying the underlying causes of patient harm.15 Our 
methodological approach used the recursive model 
of incident analysis and permitted us to capture the 
series of ‘contributing incidents’ that led to the final 
‘principal incident’ prior to the patient experiencing 
a harmful outcome.25 This meant we could provide 
Table 3 Avoidability of the 2131 new significant health 
problems identified by the first GP data collector
Avoidability classification n (%)
Totally avoidable: virtually certain evidence of 
avoidability
0 (0.0)
Probably avoidable: strong evidence of avoidability 14 (0.7)
Probably avoidable: probably avoidable, >50:50, but 
close call
18 (0.8)
Possibly avoidable: possibly avoidable, <50:50, but close 
call
19 (0.9)
Unavoidable: slight to modest evidence of avoidability 16 (0.7)
Totally unavoidable: virtually no evidence of avoidability 
(based on study team avoidability assessment)
10 (0.5)
Totally unavoidable: virtually no evidence of avoidability 
(based on GP assessment that there had been an 




Table 4 Summary of cases judged by the study team to have significant harm with at least slight to modest evidence of avoidability
Cases






<50–50, but close 
call
Probably avoidable, 









Cases from enhanced sample (first GP 
data collector)
16 19 18 14 0 67
Additional cases from 10% sample 
of enhanced sample (second GP data 
collector)
2 2 1 1 0 6
Additional case from 2.5% sample 
(not from enhanced sample)
1 0 0 0 0 1
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the most robust and comprehensive assessment of the 
patient safety incidents implicated in significant avoid-
able harm outcomes, as well as consider the apparent 
underlying events when formulating our recommenda-
tions to mitigate future risk to patients.
Only a quarter of the general practices in the strat-
ified random sample agreed to participate, and this 
is a limitation from an epidemiological perspective. 
The most common reason cited for not participating 
was lack of time. Although the characteristics of the 
practices recruited were similar to those in England 
in most respects, none of the study practices received 
an overall CQC rating of ‘inadequate’ or ‘requires 
improvement’, whereas 2.6% and 9.1% (respec-
tively) of all English practices received these ratings. 
If CQC ratings are associated with patient safety, then 
our study may underestimate the overall incidence of 
avoidable significant harm in English general prac-
tices. Our inter- rater reliability assessments showed 
that there was moderate agreement between the GPs 
in their identification of patients with significant 
health problems, and their judgements as to whether 
a patient had experienced avoidable significant harm. 
Even with our sensitivity analysis, the upper limit of 
our estimates of the incidence of avoidable signifi-
cant harm may be an underestimate. This highlights 
the uncertainties of estimates of frequency of harm 
originating from case note reviews that rely on clin-
ical judgement. It suggests that our study could have 
missed some cases of avoidable significant harm but 
could also have included cases that others might not 
consider to be ‘significant’ or ‘avoidable’.
Through our enhanced sample, we successfully iden-
tified patients most likely to have avoidable significant 
harm, but the criteria we used might be difficult to 
replicate in other countries. We did, however, manage 
to identify these patients through electronic medical 
records, and so a similar approach should be possible 
in countries with comprehensive primary care elec-
tronic records. Our study was not designed to detect 
near misses.
Comparison with other studies
We recognise from our previous systematic reviews8 10 
that comparing studies of avoidable harm is difficult 
because of different study designs and different ways 
of applying definitions of avoidable harm. One key 
difference between our study and almost all previous 
studies is that we report the incidence of avoidable 
harm rather than the prevalence (per consultation). 
Our approach allows for a clearer estimate of the 
public health burden of avoidable harm while also 
recognising that some harms, especially in a primary 
care setting, may occur over several consultations (eg, 
delayed diagnosis). Also, we have focused specifically 
on significant harm (such as a clinically important delay 
in cancer diagnosis) to ensure that our findings reflect 
Table 5 Distribution of different types of primary incidents
Types of primary incident: incidents occurring proximal 
(chronologically) to the patient outcome
At least slight to 
modest evidence of 
avoidability, n (%)








Diagnostic errors 45 (60.8) 34 (61.8) 22 (64.7)
  Wrong diagnosis—original diagnosis is found to be incorrect because the 
true cause is discovered later.
16 (21.6) 13 (23.6) 11 (32.4)
  Delayed diagnosis (non- cancer)—diagnosis could have been made earlier if 
care was evidence- based.
21 (28.4) 15 (27.3) 10 (29.4)
  Delayed cancer diagnosis 8 (10.8) 6 (10.9) 1 (2.9)
Medication errors 19 (25.7) 13 (23.6) 6 (17.6)
  No drug treatment given 4 (5.4) 3 (5.4) 2 (5.9)
  Insufficient drug treatment given 4 (5.4) 4 (7.3) 1 (2.9)
  Prescribing errors 6 (8.1) 4 (7.3) 1 (2.9)
  Monitoring errors 2 (2.7) 2 (3.6) 2 (5.9)
  Adverse drug reaction 1 (1.3) – –
  Medication not commenced in a timely manner 1 (1.3) – –
  Vaccine administration 1 (1.3) – –
Referral errors 8 (10.8) 7 (12.7) 6 (17.6)
  Delayed referral 7 (9.4) 6 (10.9) 6 (17.6)
  Referral not performed when indicated 1 (1.3) 1 (1.8) –
Other 2 (2.7) 1 (1.8) –
  Patient communication not sent from secondary to primary care 1 (1.3) 1 (1.8) –
  Incorrect test ordered 1 (1.3) – –
Total (%) 74 (100) 55 (100) 34 (100)
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Box 2 Examples of avoidable significant harm
30- week delay in diagnosing throat cancer (avoidability rating: 5, strong evidence of avoidability)
A middle- aged patient attended the general practitioner (GP) with a hoarse voice and difficulty swallowing. He reported 
that his mouth felt like the time he had thrush, which required a referral to a gastroenterologist for an endoscopy, and it 
eventually settled with an antifungal medication. In the medical records, the GP described signs of oral thrush in the mouth 
and wrote, ‘if does not settle, consider oral treatment or referral back to gastroenterologist’. Over the next 19 weeks, the 
patient returned, with six visits to the original and different GPs, with on and off ‘red flag’ symptoms that were either 
improving or worsening or of varying intensity (hoarseness, swallowing issues, odd breathing pattern, difficulty talking 
and sensation of a lump in throat) and each time was given a course of antifungal medication. From week 12, the medical 
records describe ‘food getting stuck’. At week 15, a referral for endoscopy was made and the patient was seen 1 week later. 
At this point, the patient informed the gastroenterologist he was losing weight. No abnormalities were seen on endoscopy, 
and the patient was told to go back to his GP and have his hoarse voice investigated further (with the same advice in a 
letter to the GP). Four weeks later, the patient was seen by the GP and a non- urgent referral to ears, nose and throat (ENT) 
was made. At week 30, the patient was seen by ENT, and a rare type of neck cancer was diagnosed requiring chemotherapy.
Seven- year delay in diagnosis of prostate cancer (avoidability rating: 4; probably avoidable, more than 50:50, 
but close call)
An elderly patient with type 2 diabetes mellitus attended a nurse appointment stating that he was experiencing nocturnal 
frequency. It was suspected this was due to poorly controlled diabetes, and amendments to his medication regime were 
made. Six weeks later, the patient had a telephone consultation with the GP since he was concerned about weight loss, a 
loss of appetite, increased urinary frequency and night cramps. He was booked with the GP for a face- to- face consultation 
the following day. It was also noted he had a weight loss of 2–3 kg; he was urinating at least five to six times per night; 
and he felt nauseous. The GP felt the signs and symptoms were related to poorly controlled diabetes and arranged for 
the patient to be reviewed by the practice nurse. Over the next week, blood tests (glycosylated haemoglobin and ‘urea 
and electrolytes’ (U&E)) and urine analysis were undertaken, and his antihyperglycaemic medications were amended. 
The nurse followed up the patient up a few days later, where a further drop in weight was noted. The patient reported 
some improvement in symptoms since he was now getting up at night to pass urine four instead of six times. The nurse 
advised a follow- up appointment with the GP, which did not occur until 4 weeks later. At this time, the GP noted that 7 
years previously the patient had a raised prostate- specific antigen (PSA). However, the patient had been unable to tolerate 
a biopsy for a definitive diagnosis, so 6 monthly PSA testing was advised; however, the patient did not have a follow- up 
PSA in the subsequent 7- year period. On noting this, the GP advised the patient to have a PSA test which was undertaken 
3 weeks later. The PSA measured very high (>100 ng/mL). The patient had a GP appointment 1 week later when he was 
informed his PSA was raised. An urgent ‘suspected cancer’ referral was made. He was seen by a urologist the following 
week and diagnosed with localised prostate cancer requiring a transurethral resection of the prostate.
16- month delay in diagnosing non- insulin- dependent diabetes mellitus (avoidability rating: 3; possibly 
avoidable, less than 50-50, but close call)
An impaired fasting glucose was identified in a middle- aged patient and was followed up with a glucose tolerance test 
(GTT). The patient was seen by GP (A) soon after and was informed the GTT revealed an impaired glucose tolerance and 
was given dietary and lifestyle advice. The patient was told to have a repeat test 4 months later. The patient was seen 4 
months later by a different GP (B); however, the focus of the consultation was on yellow sclerae and liver function tests 
(LFTs) were ordered. A test to assess diabetes was not requested. The patient presented 2 months later with weight loss, 
and GP (B) referred the patient for an endoscopy and a repeat LFT. A follow- up telephone call 1 month later occurred to 
discuss the LFTs with GP (B). Three months later, the patient presented to GP (B) with tiredness and fatigue. Again, blood 
tests were requested but did not include tests for diabetes. Six months later, a blood glucose was undertaken as part of 
an annual review, and following two fasting blood glucose tests 1 week apart, poorly controlled non- insulin- dependent 
diabetes mellitus was diagnosed.
Four- month delay in referral for an ischaemic limb (avoidability rating: 5, strong evidence of avoidability)
A patient in his early 60s stubbed his big toe 3 weeks prior to attending a nurse appointment at the general practice. The 
patient was known to have cardiovascular disease, including hypertension (prescribed two antihypertensives) and raised 
cholesterol (prescribed a statin). The nurse noted the toe was bruised, painful, red and had a foul odour. The patient was 
prescribed antibiotics for a presumed infection, and a referral was made to podiatry for removal of an associated ingrowing 
toenail. Four weeks later, a podiatrist was unable to detect a dorsalis pedis or posterior tibial pulse in the affected foot, 
and the patient was advised to see a GP urgently. The patient was reviewed by the GP, and a referral to a vascular surgeon 
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a health burden that is unquestionably of importance 
to patients, the public, clinicians and policy makers.
The only study we are aware of that was of a similar 
large size to ours, while also reporting on severity, 
was from a convenience sample of 48 health centres 
in Spain with health professionals reporting any inci-
dents causing harm.13 From 96 047 consultations, 
773 harms were detected with 46 of these considered 
‘severe’. Of all the harms, 64.3% were considered 
preventable, and applying this percentage to the severe 
harms suggests a prevalence of 30.8 severe harms per 
100 000 consultations. It is not possible to directly 
compare this with the incidence figures from our 
study (where the same harm may have been apparent 
across several consultations over the course of the 12 
months), but the overall rates of significant harm are 
probably not widely dissimilar.
There is considerable variation in studies reporting 
categories of avoidable harm as well as contributory 
factors. Nevertheless, our findings are in keeping with 
a systematic review that found that diagnostic errors 
were among the most important causes of avoidable 
harm,10 and a review of the global burden of diag-
nostic errors in primary care,26 while the systematic 
review10 (and other studies) has highlighted the impor-
tance of prescribing errors.13 In relation to diagnostic 
delay in cancer, a recent study has highlighted that in 
almost half of the cases, this is attributable to primary 
care,27 with problems with clinical appraisal of the 
patient and referral being particularly important. Our 
study has specifically highlighted the importance of 
delays in making a referral,15 23 and this has been high-
lighted as an important problem by the Institute for 
Healthcare Improvement.28 In comparison with other 
studies, ours is unusual in reporting such a high level 
of patient factors contributing to patient harm. While 
many of these cannot be considered the reason for the 
harm being avoidable, the findings suggest that factors 
such as multimorbidity, frailty and complex presen-
tations may make it more difficult for clinicians to 
make timely and accurate diagnosis and avoid medi-
cation errors. In relation to contributory factors that 
are avoidable, our findings are in keeping with other 
studies that have highlighted organisational issues and 
communication problems.8 12 29
Implications for clinicians and policy makers
This study has estimated the incidence of significant 
harm in English primary care considered at least 
probably avoidable, which translates to three to four 
cases per year for an average general practice of 8000 
patients. Efforts to make improvements should focus 
on addressing the structures and processes underpin-
ning the identified patient, clinician and organisational 
contributing factors. For example, better organisation 
of key systems (eg, referrals, test result management, 
identifying non- adherence) and related administra-
tion could have prevented most incidents. Some of the 
earliest patient safety studies carried out in primary 
care over two decades ago pointed to administrative 
failures, such as the mismanagement of test results, 
as the root cause of the the most common incidents 
concerning diagnosis and medication,30–32 and an 
Australian study concluded about 70% of incidents 
were related to processes of providing healthcare, 
rather than gaps in the knowledge and skills of health 
professionals.11 The current study provides consider-
able insights into the ameliorable contributory factors 
associated with avoidable significant harm in primary 
care, which in turn have generated the following 
suggestions for improvement.
More effective implementation of existing informa-
tion technology solutions could ensure that planned 
action such as referrals take place in a timely way.26 
Enhanced team coordination and communication 
could ensure that patients are seen (or have necessary 
Box 2 Continued
reviews of wound healing in the interim. At the first follow- up nurse review 1 week later, the nurse noted that the toe was 
healing, but there were no pulses with the Doppler scan, and that the patient informed the nurse he needed to sleep with 
the foot outside the bed because it was so painful. The GP saw him 3 days later and decided to make a non- urgent vascular 
referral, but the letter was not sent to the vascular surgeons for 6 weeks. The patient was seen in a vascular clinic nearly 4 
months after the podiatrist noted absent pulses and was informed that he had critical leg ischaemia and needed surgery. 
He underwent a right superficial femoral artery and posterior tibial artery (PTA) stent 4 weeks later. Some 9 months later, he 
required amputation of his big toe and second digit.
Long- term nephrotoxic medications in older adults
We observed two cases where patients with known reduced kidney function were receiving long- term potentially 
nephrotoxic drugs. One of the patients was prescribed naproxen ‘as required’ for gout but received a two times per day 
monthly supply for >12 months while concurrently receiving long- term nitrofurantoin. A hospital admission for acute- on- 
chronic kidney injury was required (avoidability rating: 5, strong evidence of avoidability).
Another patient was taking lithium and should have had 3 monthly U&E blood tests to monitor their kidney function. 
This did not happen for 15 months, and the patient was admitted with acute kidney injury (avoidability rating: 4; probably 
avoidable, more than 50:50, but close call).
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investigations) or that they are recalled for follow- up 
investigations or assessment when needed. Currently, 
it is largely down to individual primary care teams and 
individual healthcare practitioners to develop their 
own strategies. Without stifling innovation, however, 
it might be helpful to model ‘what best practice looks 
like’ in relation to preventing patients from coming 
to harm. Interventions like the ‘QRISK3–2018’ algo-
rithm to calculate a person’s risk of developing a ‘heart 
attack’ or stroke are now commonly integrated into 
electronic health record systems and used by clini-
cians to explain and manage risk and support patient 
decision- making.33 In a similar way, the factors impli-
cated in patient safety incidents that we have identified 
might be considered as signals for future algorithms for 
development and validation, either to flag up patients 
for timely clinical review to mitigate current risk levels 
or to proactively detect risks of future unsafe care.
Our study suggests that lack of continuity of care 
may contribute to avoidable significant harm in some 
cases.34 Recent systematic reviews suggest that low 
continuity of care is associated with a higher risk of 
mortality across different healthcare settings35 and 
specifically in general practice.36 In some cases in 
our study, follow- up by the same primary healthcare 
practitioner could have been helpful to enable earlier 
recognition of the progression of a serious health 
problem. In other cases, better ‘informational conti-
nuity’37 could have helped to ensure that the assess-
ment and suggested follow- up plans from a previous 
consultation better informed the next consultation. 
This should be facilitated by electronic health records, 
but we found several examples where recommenda-
tions from one consultation were not acted on in a 
subsequent consultation involving a different health-
care practitioner. Nevertheless, high levels of personal 
continuity may not always be best for patients. A 
recent qualitative study showed a mixed picture in 
terms of patients’ perceptions of whether personal 
continuity improved safety, or not,38 while a cross- 
sectional ecological study found that general practices 
that appeared to have high levels of personal conti-
nuity did fewer urgent referrals39; this does not neces-
sary mean they were less safe, but it is a potential cause 
for concern.
Some of the cases of avoidable significant harm in 
our study were associated with GPs having too many 
problems to deal with adequately in a single consul-
tation, with significant health problems not detected 
early enough because of lack of effective and timely 
clinical history taking, examination or investigation. 
Some of the contributory factors associated with 
patient behaviours may have resulted from their 
concerns being unrecognised or unresolved, as high-
lighted in a study of missed opportunities in cancer 
diagnosis.40 When such incidents occur in general 
practice, it is essential that practice teams know how 
to generate learning from the incident, including how 
to identify vulnerabilities in their existing structures 
and processes, and feel confident to plan and test 
changes that could achieve improved outcomes for 
future patients.41 The introduction of quality improve-
ment domains into 2019/2020 Quality and Outcomes 
Framework by NHS England represents a promising 
commitment for supporting practices to learn about 
and develop their approach to systems improvement42 
as does the 2019 NHS Patient Safety Strategy.43
CONCLUSION
There is likely to be a substantial burden of avoid-
able significant harm attributable to primary care 
in England with diagnostic error accounting for 
most harms, followed by medication error and 
Box 3 Underlying incidents resulting in 
delayed diagnoses (history taking, examination, 
investigation, communication and referral)
 ► Incomplete history taking (one case), for example, not 
enquiring about red flags and not documenting salient 
negatives, inaccurate medical records (two cases), 
and inadequate documentation of care delivered (one 
case).
 ► Absent or delayed physical examination (five cases), 
for example, advising patient to book another visit to 
undertake a pelvic examination.
 ► Not ordering correct investigations (three cases), for 
example, no follow- up or investigations ordered for 
an older adult with a 3- week history of diarrhoea 
with blood and mucus; the patient eventually required 
an emergency admission, and Crohn’s disease was 
diagnosed.
 ► Failing to order a necessary investigation (one case), 
for example, not testing for diabetes mellitus when 
presenting with lower urinary tract symptoms.
 ► Inappropriate responses to laboratory (three cases) or 
imaging (one case) investigations, for example, (1) not 
recognising the cut- off for diagnosing type 2 diabetes, 
(2) not arranging a follow- up chest X- ray (that had 
been advised by a radiologist) in a patient with an 
opacity seen on serial radiographs (this resulted 
in a delay in referral to respiratory medicine for an 
eventual diagnosis of lung cancer).
 ► Transfer of information about the patient, which 
included delays in the communication being sent (two 
cases) or not sent at all by secondary care (one case), 
or a communication received but not actioned in 
primary care (three cases).
 ► Incorrect advice being given to the patient (one case), 
for example, patient with insulin- dependent diabetes 
not given information about how to prepare for an 
endoscopy and the general practitioner did not inform 
secondary care the patient was diabetic.
 ► Delayed referral (seven cases), referral not made (one 
case) or referral sent to the wrong location.
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delays in making a referral once a referral decision 
had been made. Based on the contributory factors 
we found, improvements could be made through 
more effective implementation of existing informa-
tion technology, enhanced team coordination and 
communication, and greater personal and informa-
tional continuity of care.
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development, or to increase the risk, of a patient safety 
incident46
At least slight to 
modest evidence of 
avoidability, n (%)
At least possible 
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  Multimorbidity: patient has two or more chronic medical conditions 20 (17.5) 15 (17.6) 11 (23.4)
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